Mark Lipacis

Jun 22, 2026

Mark Lipacis rated CRDO as Outperform on Jun 22, 2026, setting a price target of 325. Shares have remained stable near 302.52, leaving the 325 target still in play.

May 21, 2026

On May 21, 2026, NVDA was given a Outperform rating by Mark Lipacis, with a target price of 413. The stock traded sideways with a -4.95% move, keeping the bullish thesis unresolved.

May 21, 2026

ADI received a Outperform rating from Mark Lipacis on May 21, 2026, aiming for 474. Momentum has favored the Buy call, with shares climbing from 445.48 to 445.48, rewarding those who trusted the recommendation.

May 19, 2026

On May 19, 2026, Mark Lipacis published a Outperform outlook on ALAB, with a target of 297. Shares gained 80.00%, underscoring the accuracy of the bullish outlook toward 297.

May 19, 2026

Mark Lipacis on May 19, 2026 assigned MRVL a Outperform rating, with a price target of 155. The Buy call aligned well with market performance, producing a gain of 74.65%.

May 19, 2026

On May 19, 2026, Mark Lipacis reaffirmed GFS with a Outperform rating, targeting 85. The recommendation was supported by strong follow-through as the stock rose from 89.67 to 89.67.

May 19, 2026

AMD was rated Outperform by Mark Lipacis on May 19, 2026, with a price objective of 579. A bullish response from the market helped close the gap of 27.37 to the target.

May 15, 2026

On May 15, 2026, Mark Lipacis initiated coverage on AMAT with a Outperform rating and target of 515. The stock’s climb of 46.62% since the call highlights the foresight in the rating.

May 13, 2026

Mark Lipacis issued a Outperform recommendation for CAMT on May 13, 2026, price target set at 200. Investors following the Buy call captured upside momentum, with shares now at 195.72.

May 08, 2026

On May 08, 2026, MCHP was evaluated by Mark Lipacis, who gave a Outperform rating and target of 117. So far, the Buy call awaits clearer momentum, with shares flat at 102.71.

May 08, 2026

Mark Lipacis rated MTSI as Outperform on May 08, 2026, setting a price target of 427. The call has proven timely, with shares rising 10.11% toward the price target of 427.

May 08, 2026

On May 08, 2026, ALGM was given a Outperform rating by Mark Lipacis, with a target price of 53. The stock rallied 25.80% after the rating, narrowing the gap to the target of 53 and validating the bullish stance.

May 07, 2026

ARM received a Outperform rating from Mark Lipacis on May 07, 2026, aiming for 326. Momentum has favored the Buy call, with shares climbing from 407.72 to 407.72, rewarding those who trusted the recommendation.

Apr 30, 2026

On Apr 30, 2026, Mark Lipacis published a Outperform outlook on TER, with a target of 370. Shares gained 33.05%, underscoring the accuracy of the bullish outlook toward 370.

Apr 29, 2026

NXPI was rated Outperform by Mark Lipacis on Apr 29, 2026, with a price objective of 320. A bullish response from the market helped close the gap of -3.24 to the target.

Apr 23, 2026

On Apr 23, 2026, Mark Lipacis initiated coverage on LRCX with a Outperform rating and target of 300. The stock’s climb of 58.39% since the call highlights the foresight in the rating.

Apr 23, 2026

Mark Lipacis issued a Outperform recommendation for TXN on Apr 23, 2026, price target set at 316. Investors following the Buy call captured upside momentum, with shares now at 332.28.

Apr 17, 2026

On Apr 17, 2026, ONTO was evaluated by Mark Lipacis, who gave a Outperform rating and target of 315. This case illustrates how a timely bullish rating can translate into tangible gains of 19.64%.

Mar 05, 2026

Mark Lipacis rated AVGO as Outperform on Mar 05, 2026, setting a price target of 582. Shares have remained stable near 392.13, leaving the 582 target still in play.

Feb 27, 2026

On Feb 27, 2026, QBTS was given a Outperform rating by Mark Lipacis, with a target price of 44. The stock rallied 30.14% after the rating, narrowing the gap to the target of 44 and validating the bullish stance.

Feb 13, 2026

NVMI received a Outperform rating from Mark Lipacis on Feb 13, 2026, aiming for 485. Momentum has favored the Buy call, with shares climbing from 583.1 to 583.1, rewarding those who trusted the recommendation.

Oct 30, 2025

Mark Lipacis on Oct 30, 2025 assigned KLAC a Outperform rating, with a price target of 1350. The Buy call aligned well with market performance, producing a gain of 121.64%.